Evicenter
MarkdownMedical informationP&T meetings
Palazestrant (OP-1250)

Previously treated ER-positive HER2-negative advanced or metastatic breast cancer

Manufacturer
Olema Oncology
Last updated
256 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Previously treated ER-positive HER2-negative advanced or metastatic breast cancer

Economic burden and healthcare resource utilization

13 evidence topics · 16 sources